# A 6-months Observational Study to Evaluate the Quality of Life of Patients Treated With Phytotherapy or Alpha-blockers for Benign Prostatic Hyperplasia

> **NCT07144709** · — · COMPLETED · sponsor: **Pierre Fabre Medicament** · enrollment: 288 (actual)

## Conditions studied

- Benign Prostatic Hyperplasia

## Interventions

- **DRUG:** Phytotherapy

## Key facts

- **NCT ID:** NCT07144709
- **Lead sponsor:** Pierre Fabre Medicament
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-22
- **Primary completion:** 2024-07-29
- **Final completion:** 2024-07-29
- **Target enrollment:** 288 (ACTUAL)
- **Last updated:** 2025-08-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07144709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07144709, "A 6-months Observational Study to Evaluate the Quality of Life of Patients Treated With Phytotherapy or Alpha-blockers for Benign Prostatic Hyperplasia". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07144709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*